PTPRC and endometrial carcinoma: Despite an overall increase in the number of CD45+ and CD3+ cells in endometrial carcinomas, as a percentage of total mixed cells (Figure 1C) and CD45+ cells (Figure 1D), their respective proportions did not change between tumor and adjacent tissue.